Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Bonds Calmer, FDA OK's J&J Vaccine, Zoom Earnings - What's up in Markets

EconomyMar 01, 2021 19:13
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters

By Geoffrey Smith 

Investing.com -- Central banks push back against the bond market bears, pushing yields down. The manufacturing recovery in China slows, but Europe's and Japans accelerates. The ISM survey is due at 10 AM, along with construction spending data. The FDA approved Johnson & Johnson (NYSE:JNJ)'s Covid-19 vaccine. Stocks are set to open higher, with Walmart and Zoom Video in focus, and crude oil prices are also up after Iran rejected talks with the U.S., underlining that the path to lifting sanctions on its exports will be long and bumpy. Here's what you need to know in financial markets on Monday, March 1st.

1. Australia leads central bank pushback against bond bears 

The bond market volatility that dominated last week’s trading has subsided, with the first concrete sign of central banks pushing back against those pushing yields higher in anticipation of higher inflation.

The Reserve Bank of Australia bought twice the scheduled amount of long-term bonds at its regular quantitative easing operation overnight, following on from its intervention to keep three-year bond yields at their target level last week. The European Central Bank will also publish later details of its bond purchases last week, which should show how keen the ECB was to avoid what it calls an “unwarranted tightening of financial conditions.”

The Federal Reserve’s John Williams and Lael Brainard may both weigh in on the bond market developments in speeches at 9 AM ET (1400 GMT) and 9:05 (1405) AM ET, respectively. The yield on the U.S. 10-Year note fell back to 1.43% overnight, while the German 10-Year yield fell to -0.30%.

2. China recovery plateaus but Japan, Europe pick up speed; ISM survey due

The economic rebound underlying that bond market sell-off appeared largely intact in the latest round of business surveys around the world. The Japanese purchasing managers index rose to its highest in over two years, while South Korea posted another strong month of exports and imports.

Final PMIs for February were also revised up across most of Europe, with Eurozone manufacturing posting its best reading since early 2018, at 57.9, and the U.K. manufacturing PMI being revised up to 55.1.

China’s Caixin PMI, however, fell to its lowest in nine months. Analysts said the figures were distorted by the timing of the Lunar New Year holiday, but the monthly drop was the third in a row and took the index to its lowest in nine months, suggesting that China’s manufacturing recovery is plateauing.

The Institute of Supply Management's manufacturing survey is due at 10 AM ET, along with data on construction spending.

3. Stocks set to open higher after House passes Covid relief bill

U.S. stock markets are set to open higher against the calmer bond market backdrop, able to focus on the progress of the administration’s $1.9 trillion stimulus bill on Saturday.

By 6:20 AM ET, Dow Jones futures were up 273 points, or 0.9%, while S&P 500 futures were up 1.0% and Nasdaq 100 futures were up 1.2%, all three indexes trimming overnight gains somewhat.

Stocks likely to be in focus later include Walmart (NYSE:WMT), which was reported at the weekend to have hired two senior Goldman Sachs (NYSE:GS) executives to accelerate its plans for a banking operation. The reports may also have a read-across to consumer banking stocks, given the implications for tougher competition.

While earnings season is all but over, Zoom Video Communications’ quarterly update is likely to garner attention, given the recent cooling in the stock price on fears that the Working-From-Home boom may have peaked as the economy prepares to reopen.

4. FDA authorizes Johnson & Johnson vaccine

The reopening process got a fresh boost at the weekend as the Food and Drug Administration gave emergency use authorization to Johnson & Johnson’s single-shot vaccine against Covid-19.

The J&J drug is the third vaccine to receive EUA in the U.S. and promises to expand the supply of safe and effective drugs against Covid-19 significantly. Preliminary data suggest it is also largely effective in stopping the spread of disease by people who don’t have symptoms of the disease, an important source of transmission.

Elsewhere, reports suggested that Germany is to reconsider its decision not to approve AstraZeneca’s vaccine for use by over-65s, a decision that has slowed the rollout of vaccines in Europe’s largest economy.

5. Crude oil resumes rally as Iran rejects talks with U.S.

Crude oil futures resumed their upward march against a backdrop of broader risk appetite. Also supporting the move was news over the weekend that Iran had rejected an offer of direct talks with the U.S. over a return to the 2015 UN-backed non-proliferation agreement.

Both the U.S. and Iran are currently in breach of the agreement, with Iran refining uranium metal that analysts say can be adapted for use in nuclear bombs, and the U.S. applying sanctions that have badly hurt Iranian crude exports and the rest of its economy.

By 6 AM ET, U.S. crude futures were up 1.3% at $62.30 a barrel, while Brent crude was up 1.2% at $65.21 a barrel. 

Analysts say the rally  may be challenged by the start of maintenance season at China’s refineries, slowing demand for crude imports for a while.

Bonds Calmer, FDA OK's J&J Vaccine, Zoom Earnings - What's up in Markets
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email